I think that pent ermine is a dangerous drug to use in categories at risk. Topiramate is a safe drug with frequent side effects. I am skeptical about its approval and use in UE.
I don't think so. The drug you are talking about (Qsymia) is an association of topiramate with phentermine. Currently, the European Medication Agency (EMA) do not authorise phentermine for clinical use in humans. Moreover, according to the EMA opinion, the clinical use of topiramate is also unauthorised in obesity tretatment. Therefore its is highly improbable that Qsymia could get the EMA approval. Moreover